The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis

Journal of Cellular Physiology

Volumn 220, Issue 3, 2009, Pages 780-791

  Haupt, Larisa M ^a,d   Murali, Sadasivam ^a   Foong, Kin Mun ^a   Teplyuk, Nadiya ^b   Leong, Fong Mei ^a   Stein, Gary S ^b   Van Wijnen, Andre J ^b   Nurcombe, Victor ^a   Cool, Simon M ^a,c  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; BONE MORPHOGENETIC PROTEIN 2; CHONDROITIN; DECORIN; DERMATAN SULFATE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLYCOSAMINOGLYCAN; GLYPICAN 3; HEPARANASE; PROTEOHEPARAN SULFATE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; VERSICAN; CSPG2 PROTEIN, MOUSE; GLYPICAN; HEPARIN LYASE; MESSENGER RNA; PROTEOGLYCAN; RECOMBINANT PROTEIN; RUNX2 PROTEIN, MOUSE; SCLEROPROTEIN; SULFOTRANSFERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE TECHNIQUE; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; MOUSE; NONHUMAN; NULL CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SULFATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CELL LINEAGE; CELL PROLIFERATION; CELL STRAIN 3T3; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PROTEIN PROCESSING; RNA INTERFERENCE; TIME;

3T3 CELLS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYPICANS; HEPARIN LYASE; HUMANS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOGLYCANS; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; SULFOTRANSFERASES; TIME FACTORS; TRANSFECTION; VERSICANS;

EID: 67650375956     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21825     Document Type: Article

References (40)

1. Bae JS, Gutierrez S, Narla R, Pratap J, Devados R, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Javed A. 2007. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation. J Cell Biochem 100:434-449.
2. Bame KJ, Venkatesan I, Stelling HD, Tumova S. 2000. The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases. Glycobiology 10:715-726.
3. Birch MA, Skerry TM. 1999. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones. Bone 24:571-578.
4. Bishop JR, Schuksz M, Esko JD. 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030-1037.
5. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB. 2002. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640.
6. Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE. 1998. Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273:4350-4359.
7. Capila I, Linhardt RJ. 2002. Heparin-protein interactions. Angew Chem Int Ed Engl 41: 391-412.
8. Fan QW, Uchimura K, Yuzawa Y, Matsuo S, Mitsuoka C, Kannagi R, Muramatsu H, Kadomatsu K, Muramatsu T. 1999. Spatially and temporally regulated expression of N-acetylglucosamine-6-O-sulfotransferase during mouse embryogenesis. Glycobiology 9:947-955.
9. Feyzi E, Saldeen T, Larsson E, Lindahl U, Salmivirta M. 1998. Age-dependent modulation of heparan sulfate structure and function. J Biol Chem 273:13395-13398.
10. Gallagher JT, Turnbull JE, Lyon M. 1992. Patterns of sulphation in heparan sulphate: Polymorphism based on a common structural theme. Int J Biochem 24:553-560.
11. Gama CI, Tully SE, Sotogaku N, Clark PM, Rawat M, Vaidehi N, Goddard WA III, Nishi A, Hsieh-Wilson LC. 2006. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat Chem Biol 2:467-473.
12. Grobe K, Esko JD. 2002. Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/ n-sulfotransferase isozymes by structured 5′-untranslated regions and internal ribosome entry sites. J Biol Chem 277:30699-33706.
13. Grobe K, Ledin J, Ringvall M, Holmborn K, Forsberg E, Esko JD, Kjellen L. 2002. Heparan sulfate and development: Differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim Biophys Acta 1573:209-215.
14. Habuchi H, Habuchi O, Kimata K. 2004. Sulfation pattern in glycosaminoglycan: Does it have a code? Glycoconj J 21:47-52.
15. Hacker U, Nybakken K, Perrimon N. 2005. Heparan sulphate proteoglycans: The sweet side of development. Nat Rev Mol Cell Biol 6:530-541.
16. Hecht JT, Hogue D, Wang Y, Blanton SH, Wagner M, Strong LC, Raskind W, Hansen MF, Wells D. 1997. Hereditary multiple exostoses (EXT): Mutational studies of familial EXT1 cases and EXT-associated malignancies. Am J Hum Genet 60:80-86.
17. Jayson GC, Lyon M, Paraskeva C, Turnbull JE, Deakin JA, Gallagher JT. 1998. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem 273:51-57.
18. Johnson CE, Crawford BE, Stavridis M, TenDam G, Wat AL, Rushton G, Ward CM, Wilson V, van Kuppevelt TH, Esko JD, Smith A, Gallagher JT, Merry CL. 2007. Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells 25:1913-1923.
19. Kjellen L, Bielefeld D, Hook M. 1983. Reduced sulfation of liver heparan sulfate in experimentally diabetic rats. Diabetes 32:337-342.
20. Kluppel M, Wight TN, Chan C, Hinek A, Wrana JL. 2005. Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development 132:3989-4003.
21. Kreuger J, Spillmann D, Li JP, Lindahl U. 2006. Interactions between heparan sulfate and proteins: The concept of specificity. J Cell Biol 174:323-327.
22. Lamoureux F, Baud'huin M, Duplomb L, Heymann D, Redini F. 2007. Proteoglycans: Key partners in bone cell biology. Bioessays 29:758-771.
23. Lazarus JE, Hegde A, Andrade AC, Nilsson O, Baron J. 2007. Fibroblast growth factor expression in the postnatal growth plate. Bone 40:577-586.
24. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein JL, Stein GS. 2004. Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14:1-41.
25. Lin X, Buff EM, Perrimon N, Michelson AM. 1999. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126:3715-3723.
26. Lindahl U, Kusche-Gullberg M, Kjellen L. 1998. Regulated diversity of heparan sulfate. J Biol Chem 273:24979-24982.
27. Ling L, Murali S, Dombrowski C, Haupt LM, Stein GS, van Wijnen AJ, Nurcombe V, Cool SM. 2006. Sulfated glycosaminoglycansmediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J Cell Physiol 209:811-825.
28. Molteni A, Modrowski D, Hott M, Marie PJ. 1999. Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to fibroblast growth factor-2 in cultured rat mandibular condyle and calvaria. Cell Tissue Res 295:523-536.
29. Nurcombe V, Goh FJ, Haupt LM, Murali S, Cool SM. 2007. Temporal and functional changes in glycosaminoglycan expression during osteogenesis. J Mol Histol 38:469-481.
30. Safaiyan F, Lindahl U, Salmivirta M. 1998. Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells. Eur J Biochem 252:576-582.
31. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U. 2002. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2:521-528.
32. Sedita J, Izvolsky K, Cardoso WV. 2004. Differential expression of heparan sulfate 6-O-sulfotransferase isoforms in the mouse embryo suggests distinctive roles during organogenesis. Dev Dyn 231:782-794.
33. Sugahara K, Kitagawa H. 2002. Heparin and heparan sulfate biosynthesis. IUBMB Life 54:163-175.
34. Teplyuk NM, Haupt LM, Ling L, Dombrowski C, Mun FK, Nathan SS, Lian JB, Stein JL, Stein GS, Cool SM, van Wijnen AJ. 2009. The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts. J Cell Biochem 107:144-154.
35. The I, Bellaiche Y, Perrimon N. 1999. Hedgehog movement is regulated through tout velu-dependent synthesis of a heparan sulfate proteoglycan. Mol Cell 4:633-639.
36. Toyoshima M, Nakajima M. 1999. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 274:24153-24160.
37. Viviano BL, Silverstein L, Pflederer C, Paine-Saunders S, Mills K, Saunders S. 2005. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification. Dev Biol 282:152-162.
38. Wilson VA, Gallagher JT, Merry CL. 2002. Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development. Glycoconj J 19:347-354.
39. Woei Ng K, Speicher T, Dombrowski C, Helledie T, Haupt LM, Nurcombe V, Cool SM., 2007. Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors. Stem Cells Dev 16:305-318.
40. Yusa A, Kitajima K, Habuchi O. 2006. N-linked oligosaccharides on chondroitin 6-sulfotransferase-1 are required for production of the active enzyme, Golgi localization, and sulfotransferase activity toward keratan sulfate. J Biol Chem 281:20393-22403.